|
Volumn 12, Issue 4, 2002, Pages 637-640
|
Substituted N-(3,5-dichlorobenzenesulfonyl)-L-prolyl-phenylalanine analogues as potent VLA-4 antagonists
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA1 INTEGRIN;
BIO 1211;
CD29 ANTIGEN ANTAGONIST;
PHENYLALANINE DERIVATIVE;
TR 14035;
UNCLASSIFIED DRUG;
VASCULAR CELL ADHESION MOLECULE 1;
BENZENESULFONYL CHLORIDE;
DIPEPTIDE;
PHENYLALANINE;
SULFONE;
VERY LATE ACTIVATION ANTIGEN 4;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG POTENCY;
DRUG PROTEIN BINDING;
DRUG SYNTHESIS;
IC 50;
NONHUMAN;
RAT;
ANIMAL;
BIOAVAILABILITY;
CHEMISTRY;
DOG;
DRUG ANTAGONISM;
DRUG EFFECT;
HAPLORHINI;
METABOLIC CLEARANCE RATE;
SHEEP;
SPRAGUE DAWLEY RAT;
STRUCTURE ACTIVITY RELATION;
SYNTHESIS;
ANIMALS;
BIOLOGICAL AVAILABILITY;
DIPEPTIDES;
DOGS;
HAPLORHINI;
INHIBITORY CONCENTRATION 50;
INTEGRIN ALPHA4BETA1;
METABOLIC CLEARANCE RATE;
PHENYLALANINE;
RATS;
RATS, SPRAGUE-DAWLEY;
SHEEP;
STRUCTURE-ACTIVITY RELATIONSHIP;
SULFONES;
VASCULAR CELL ADHESION MOLECULE-1;
|
EID: 18244399393
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(01)00821-6 Document Type: Article |
Times cited : (18)
|
References (11)
|